Madrigal Pharmaceuticals Q3 EPS $(1.39) Down From $(0.56) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(1.39) per share. This is a 148.21 percent decrease over losses of $(0.56) per share from the same period last year.

Benzinga · 11/06/2019 12:39

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(1.39) per share. This is a 148.21 percent decrease over losses of $(0.56) per share from the same period last year.